Regulatory Drug Advertising and Promotion
Optimizing your marketing strategies to meet regulatory compliance
Regulatory Drug Advertising & Promotions Consulting
Pre-Market Review
- Consultation on the use of global vs. local advertising concepts
- Product Monograph review
- Review Advertising Launch materials
- Pre-NOC messaging
- Consultation on Direct-to-Consumer Information (DTCI)
Marketed Products
- Advertising complaints and provide guidance on the PAAB complaint process
- Review advertising materials; Directed to Healthcare Professional (HCP), Patient-directed materials
- Consultation on promotional activities; Use of reprints, Online promotions, Websites, Learning activities
- Use of global initiatives into the Canadian market
- Direct-to-Consumer Advertising and Information (DTCA/DTCI)
Training
Internal staff training
Understand the Advertising Regulatory landscape
Our Regulatory Drug Advertising & Promotions Leader
Brenda Gryfe, Director of Regulatory Affairs
Brenda Gryfe is a pharmacist with over 25 years of experience in the pharmaceutical industry in a variety of therapeutic areas, including women’s health and cardiology. Before joining TPIreg in 2014, Ms. Gryfe has held positions in Regulatory Affairs, Medical Affairs, Medical Communications, Pharmacovigilance and Clinical Research. She has a business-focused understanding of Regulatory Affairs, gained from experience across several companies, including Procter and Gamble.
She provides support to promotional material development teams with regulatory advice and review services for the unique drug advertising environment in Canada. Ms. Gryfe has guided Regulatory teams through a variety of pre- and post-approval regulatory processes, including strategically complex submissions. Since doing research in seniors’ understanding of prescription drug labels at the University of Toronto, Ms. Gryfe retains a particular interest in drug labeling, including patient education materials.
